Lucida Medical raises £8.7m to expand same-day cancer diagnostics platform

Lucida Medical has raised £8.7m to expand its AI-based cancer diagnostics platform in a new funding round led by IW Capital and supported by existing investors XTX Ventures and Macmillan Cancer Support. The UK-based healthtech company develops AI software designed to support clinicians in diagnosing prostate cancer from MRI scans more quickly and consistently. The…